Flexible Benefits

The most important benefit you can provide for your employees is affordable cancer screening.

Our clinically led and validated services cover the six most common cancers in the UK, which are Bowel, Breast, Cervical, Lung, Prostate and Skin cancers. 

  • Not just a test, but a full screening service
  • Screening programmes based on personal risk
  • Affordable, effective, and clinically recognised
  • Education, Awareness, and Prevention
  • Onward support and advice from clinical experts
  • Check4Cancer is trusted to provide diagnostic pathways for many of the leading UK Private Medical Insurers  

 

We can offer your employees the following Flexible Benefits

Mammogram

Who is it for?

  • Women aged 40+ with NO symptoms of breast cancer   

Please visit our breast cancer symptoms page here.

Why get checked?

  • Several large studies around the world show that breast cancer screening with mammograms reduces the number of deaths from breast cancer in women aged between 40-69, especially in those aged 50+.
  • By detecting breast cancer at an early stage, breast screening using mammography has helped to reduce the death rate of breast cancer in women aged 50+ in the UK.

How it works?

This service requires the employee to attend a private clinic which is arranged through our customer call centre.

  • A screening mammogram is an X-ray of the breast used to detect breast changes in women who have NO signs or symptoms of breast cancer.
  • Our screening mammograms are double reported by two specialist consultant breast radiologists.
  • If an abnormality is found it will help to reduce the time to diagnosis, ensuring any treatment that is needed can be started straight away.
MyBreastRisk

Who is it for?

  • Women aged 30+

*MyBreastRisk is not suitable for women who have been diagnosed with breast cancer, including women with triple negative or bilateral breast cancer, and those diagnosed under age 45.

* Breast SNP tests are based on a cohort of Caucasian European patients. Published data in August 2021 has confirmed breast SNP tests should not be used to predict risk in women of other ethnicities. Check4Cancer therefore only recommends our SNP test for Caucasian European ethnicities.

Why get checked?

  • By performing this one-off DNA test an employee will be empowered to take control of their own breast cancer risk and ensure that they are having the most appropriate screening.
  • They will be able to make lifestyle choices and behaviour changes that will protect them in the future.

How it works?

Easy to use at-home DNA testing kit that combines genetic, family history and lifestyle factors to determine a woman’s personal lifetime breast cancer risk.

  • An online breast cancer risk-assessment questionnaire based on the validated Tyrer-Cuzick model*.
  • Saliva DNA at-home sample collection kit.
  • Once the employee has completed the sample, they simply return it in the prepaid envelope to our laboratory and will receive their results within 8 weeks.
  • Results of Lifetime Risk of developing breast cancer and a personalised screening programme based on the woman’s personal risk of developing breast cancer. There are three risk categories, Average, Moderate or High Risk. 
  • Anyone considered to be within the ‘High Risk’ category will be offered a free genetic counselling session to discuss specific risk reduction strategies or further genetic testing.

*The Tyrer-Cuzick model, or IBIS tool, is used to estimate the likelihood of a woman developing breast cancer over the course of her lifetime.

LungCheck

Who is it for?

  • Men and women aged 50+*

*A 20 -pack smoking history or less than a 20 -pack smoking history as well as a close family history of lung cancer (parent, sibling, child).

Why get checked?

  • LungCheck is for past or current heavy smokers, or who have a close family relative (parent, sibling, child) who has been diagnosed with lung cancer.
  • The chances of survival from lung cancer are extremely good if detected early as often the majority of people with the early stages of lung cancer have no apparent symptoms.

How it works?

Easy to use at-home lung cancer screening test kit:

  • Online risk assessment questionnaire.
  • A simple blood collection kit (finger prick).
  • A unique blood test (EarlyCDT® - Lung) which allows more accurate targeting of the use of CT scanning and is seven times more likely to correctly diagnose lung cancer.
  • Once the employee has completed the test, they simply return it in the prepaid envelope to our laboratory.
  • Results and a personalised screening programme within 2 weeks.
PSACheck

Who is it for?

  • Men aged 40 +

Why get checked?

  • Prostate cancer is the most common cancer in men across the UK with more than 47,700 men diagnosed with prostate cancer every year.
  • Men with prostate cancer often have no symptoms, unless the disease is detected at a late stage, and there is currently no national NHS screening programme for prostate cancer, so screening is vital.

How it works?

Easy to use at-home prostate cancer screening test kit:

  • Online risk assessment questionnaire.
  • A simple blood collection kit (finger prick) which will test for Free and Total PSA (prostate specific antigen).
  • Once the employee has completed the test, they simply return it in the prepaid envelope to our laboratory.
  • Results and a personalised screening programme within 1 week.
HPVCheck

Who is it for?

  • Women aged 25+

Why get checked?

  • HPV stands for Human papillomavirus. It is a sexually transmitted virus that is extremely common - with four in five people exposed to the virus at some point in their lives. HPV is the cause of 99.7% of all cervical cancers.
  • Cervical cancer is 100% preventable and if detected in the early stages is highly treatable with a 90% cure rate.

How it works?

Easy to use at-home cervical cancer screening test kit:

  • An online cervical cancer risk assessment questionnaire.
  • A sample-wand collection kit with easy to follow step-by-step instructions.
  • Once the employee has completed the test, they simply return it in the prepaid envelope to our laboratory.
  • Results and a personalised screening programme within 5 days.
  • All 13 HPV sub-types are reported individually. Our test reports on all 13 sub- types including HPV 16,18,3, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68.
BowelCheck

Who is it for?

  • Men and women aged 45+

Why get checked?

  • If bowel cancer (also known as colon cancer, rectal cancer or colorectal cancer) can be detected in its earliest stages, there is a greater than 90% chance of it being cured.
  • 50% of bowel cancer is preventable in the UK by screening and reducing risks.

How it works?

BowelCheck is a quantitative Faecal Immunochemical Test (qFIT) that detects the amount of human blood in the faeces, as this can be a sign of bowel cancer.

Easy to use at-home bowel cancer screening test kit:

  • An on-line bowel cancer risk assessment questionnaire.
  • A sample collection kit containing easy to follow step-by-step instructions.
  • Once the employee has completed the sample test, they simply return it in the prepaid envelope to our laboratory.
  • Results and a personalised screening programme within five days.
SkinCheck

Who is it for?

  • Men and women aged 18+

Why get checked?

  • Skin cancer is the most common form of cancer in the UK, however, 86% of skin cancers can be prevented and there is a 98% survival rate if skin cancer is caught early versus 16% if caught late.
  • SkinCheck empowers employees to become skin aware and take precautions to reduce their risk of skin cancer.

How it works?

Clinical face to face appointment with a specialist skin cancer nurse:

  • An online melanoma risk assessment.
  • Full body examination by specialist skin cancer nurse.
  • Digital and dermoscopic images of abnormal lesions/moles.
  • Images reported by a skin cancer consultant.
  • Tuition in self-examination and being skin aware.
  • Lesion by lesion results letter within 5 days, including digital images.

We work with some of the world's leading companies, take a look at our impressive client list.

Professor Gordon Wishart, Chief Medical Officer

Our screening programmes have been designed by national and international cancer experts to provide innovate tests that have been clinically validated. In winning an award at the 2018 Health Investor Awards for our rapid access cancer diagnostic pathways, I was delighted that the judges recognised Check4Cancer’s commitment to deliver patient-centred, medically-led early cancer detection services.